Generic Supplement 2013
Efforts are under way in some states to restrict the pharmacist's ability to select generics.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First-in-Class Daraxonrasib for Metastatic Pancreatic Cancer
2
What Pharmacists Should Know About Novo Nordisk-Eli Lilly GLP-1 Ad Suit
3
FDA Approves Dolutegravir for HIV Treatment in Newborns
4
FDA Clears First Continuous Glucose-Ketone Monitor
5